BMJ Best Practice

参考文献

关键文献

Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ. 1993;307:982-986.

Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2017. [internet publication]

FitzGerald J M, Gibson PG. Asthma exacerbations. 4: Prevention. Thorax. 2006:61:992-999.

National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program expert panel report 3: guidelines for the diagnosis and management of asthma. July 2007. http://www.nhlbi.nih.gov (last accessed 14 September 2016).

Rodrigo GJ, Castro-Rodriguez JA. Safety of long-acting beta agonists for the treatment of asthma: clearing the air. Thorax. 2012;67:342-349.

Watts K, Chavasse RJ. Leukotriene receptor antagonists in addition to usual care for acute asthma in adults and children. Cochrane Database Syst Rev. 2012;(5):CD006100.

O'Byrne PM, Barnes PJ, Rodriguez-Roisin R, et al. Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med. 2001;164:1392-1397.

参考文章

1.  Braman SS. The global burden of asthma. Chest. 2006;130(1 Suppl):4S-12S.

2.  Health & Social Care Information Centre. Provisional monthly hospital episode statistics for admitted patient care, outpatient and accident and emergency data - April 2012 to July 2012 (Asthma). November 2012. http://www.hscic.gov.uk (last accessed 12 September 2016).

3.  Krishnan V, Diette GB, Rand CS, et al. Mortality in patients hospitalized for asthma exacerbations in the United States. Am J Respir Crit Care Med. 2006;174:633-638.

4.  Johnston NW, Sears MR. Asthma exacerbations. 1: epidemiology. Thorax. 2006;61:722-728.

5.  Nicholson PJ, Cullinan P, Burge PS, et al. Occupational asthma: prevention, identification & management: systematic review & recommendations. March 2010. http://www.bohrf.org.uk (last accessed 14 September 2016).

6.  Singh AM, Busse WW. Asthma exacerbations. 2: Aetiology. Thorax. 2006;61:809-816.

7.  Wark PA, Gibson PG. Asthma exacerbations. 3: Pathogenesis. Thorax. 2006;61:909-915.

8.  Carroll NG, Mutavdzic S, James AL. Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma. Thorax. 2002;57:677-682.

9.  Wood LG, Garg ML, Blake RJ, et al. Airway and circulating levels of carotenoids in asthma and healthy controls. J Am Coll Nutr. 2005;24:448-455.

10.  Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ. 1993;307:982-986.

11.  Biscardi S, Lorrot M, Marc E, et al. Mycoplasma pneumoniae and asthma in children. Clin Infect Dis. 2004;38:1341-1346.

12.  Cunningham AF, Johnston SL, Julious SA, et al. Chronic Chlamydia pneumoniae infection and asthma exacerbations in children. Eur Respir J. 1998;11:345-349.

13.  Miyashita N, Kubota Y, Nakajima M, et al. Chlamydia pneumoniae and exacerbations of asthma in adults. Ann Allergy Asthma Immunol. 1998;80:405-409.

14.  Emre U, Sokolovskaya N, Roblin PM, et al. Detection of anti-Chlamydia pneumoniae IgE in children with reactive airway disease. J Infect Dis. 1995;172:265-267.

15.  Thomson NC, Chaudhuri R, Livingston E. Asthma and cigarette smoking. Eur Respir J. 2004;24:822-833.

16.  Bernstein JA, Alexis N, Barnes C, et al. Health effects of air pollution. J Allergy Clin Immunol. 2004;114:1116-1123.

17.  Tarlo SM, Balmes J, Balkissoon R, et al. Diagnosis and management of work-related asthma: American College Of Chest Physicians Consensus Statement. Chest. 2008;134(3 suppl):1S-41S.

18.  Orellano P, Quaranta N, Reynoso J, et al. Effect of outdoor air pollution on asthma exacerbations in children and adults: Systematic review and multilevel meta-analysis. PLoS One. 2017 Mar 20;12(3):e0174050.

19.  World Health Organization. WHO guidelines for indoor air quality: dampness and mould. 2009. http://www.euro.who.int (last accessed 14 September 2016).

20.  Havemann B, Henderson CA, El-Serag HB. The association between gastroesophageal reflux disease and asthma: a systematic review. Gut. 2007;56:1654-1664.

21.  Martinez FD, Wright AL, Taussig LM, et al; The Group Health Medical Associates. Asthma and wheezing in the first six years of life. N Engl J Med. 1995;332:133-138.

22.  Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2017. [internet publication]

23.  Chauhan BF, Jeyaraman MM, Singh Mann A, et al. Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma. Cochrane Database Syst Rev. 2017 Mar 16;3:CD010347.

24.  FitzGerald J M, Gibson PG. Asthma exacerbations. 4: Prevention. Thorax. 2006:61:992-999.

25.  Ring N, Malcolm C, Wyke S, et al. Promoting the use of Personal Asthma Action Plans: a systematic review. Prim Care Respir J. 2007;16:271-283.

26.  Jolliffe DA, Greenberg L, Hooper RL, et al. Vitamin D supplementation to prevent asthma exacerbations: a systematic review and meta-analysis of individual participant data. Lancet Respir Med. 2017 Nov;5(11):881-890.

27.  Martineau AR, Cates CJ, Urashima M, et al. Vitamin D for the management of asthma. Cochrane Database Syst Rev. 2007;(3):CD0030002016 Sep 5;9:CD011511.

28.  Ford ES, Mannino DM, Williams SG. Asthma and influenza vaccination: findings from the 1999-2001 National Health Interview Surveys. Chest. 2003;124:783-789.

29.  Moreira A, Bonini M, Garcia-Larsen V, et al. Weight loss interventions in asthma: EAACI evidence-based clinical practice guideline (part I). Allergy. 2013;68:425-439.

30.  British Thoracic Society; Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma: a national clinical guideline. September 2016 [internet publication].

31.  Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: 2019 report. 2019 [internet publication].

32.  Jackson H, Hubbard R. Detecting chronic obstructive pulmonary disease using peak flow rate: cross sectional survey. BMJ. 2003 Sep 20;327(7416):653-4.

33.  McFadden E R Jr, Gilbert IA. Exercise-induced asthma. N Engl J Med. 1994;330:1362-1367.

34.  Parsons JP, Mastronarde JG. Exercise-induced bronchoconstriction in athletes. Chest. 2005;128:3966-3974.

35.  McCullough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation. 2002:106:416-22.

36.  Wells PS, Anderson DR, Rodger M, et al. Derivation of a simple clinical model to categorize patients' probability of pulmonary embolism: increasing the model's utility with the SimpliRED D-dimer. Thromb Haemost. 2000 Mar;83(3):416-20.

37.  Greenberger PA. Clinical aspects of allergic bronchopulmonary aspergillosis. Front Biosci. 2003;8:s119-s127.

38.  National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program expert panel report 3: guidelines for the diagnosis and management of asthma. July 2007. http://www.nhlbi.nih.gov (last accessed 14 September 2016).

39.  Kew KM, Quinn M, Quon BS, Ducharme FM. Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children. Cochrane Database Syst Rev. 2016 Jun 7;(6):CD007524.

40.  Rodrigo GJ, Castro-Rodriguez JA. Safety of long-acting beta agonists for the treatment of asthma: clearing the air. Thorax. 2012;67:342-349.

41.  Papi A, Mansur AH, Pertseva T, et al. Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations. J Aerosol Med Pulm Drug Deliv. 2016 Aug;29(4):346-61.

42.  Watts K, Chavasse RJ. Leukotriene receptor antagonists in addition to usual care for acute asthma in adults and children. Cochrane Database Syst Rev. 2012;(5):CD006100.

43.  Chan WW, Chiou E, Obstein KL, et al. The efficacy of proton pump inhibitors for the treatment of asthma in adults: a meta-analysis. Arch Intern Med. 2011;171:620-629.

44.  Kravitz J, Dominici P, Ufberg J, et al. Two days of dexamethasone versus 5 days of prednisone in the treatment of acute asthma: a randomized controlled trial. Ann Emerg Med. 2011;58:200-204.

45.  Rodrigo GJ. Rapid effects of inhaled corticosteroids in acute asthma: an evidence-based evaluation. Chest. 2006;130:1301-1311.

46.  Rodrigo GJ, Nannini LJ. Comparison between nebulized adrenaline and beta2 agonists for the treatment of acute asthma: a meta-analysis of randomized trials. Am J Emerg Med. 2006;24:217-222.

47.  Kirkland SW, Vandenberghe C, Voaklander B, et al. Combined inhaled beta-agonist and anticholinergic agents for emergency management in adults with asthma. Cochrane Database Syst Rev. 2017 Jan 11;1:CD001284.

48.  Kew KM, Kirtchuk L, Michell CI. Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department. Cochrane Database Syst Rev. 20052014 May 28;(25):CD001276CD010909.

49.  Knightly R, Milan SJ, Hughes R, et al. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev. 2017 Nov 28;11:CD003898.

50.  Colebourn CL, Barber V, Young JD. Use of helium-oxygen mixture in adult patients presenting with exacerbations of asthma and chronic obstructive pulmonary disease: a systematic review. Anaesthesia. 2007;62:34-42.

51.  Rodrigo G, Pollack C, Rodrigo C, et al. Heliox for nonintubated acute asthma patients. Cochrane Database Syst Rev. 2006;(4):CD002884.

52.  Soar J, Nolan JP, Böttiger BW, et al; Adult advanced life support section collaborators. European Resuscitation Council Guidelines for resuscitation 2015: section 3. Adult advanced life support. Resuscitation. 2015 Oct;95:100-47.

53.  Colquhoun MC, Handley AJ, Evans TR, eds. ABC of resuscitation. 5th ed. Wiley-Blackwell; 2004.

54.  Soar J, Nolan JP, Böttiger BW, et al. European Resuscitation Council guidelines for resuscitation 2015: Section 3. Adult advanced life support. Resuscitation. 2015;95:100-147.

55.  Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43:343-373.

56.  Petsky HL, Li A, Chang AB. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults. Cochrane Database Syst Rev. 2017 Aug 24;8:CD005603.

57.  Petsky HL, Kew KM, Turner C, Chang AB. Exhaled nitric oxide levels to guide treatment for adults with asthma. Cochrane Database Syst Rev. 2016 Sep 1;9:CD011440.

58.  Rodrigo G, Rodrigo C, Burschtin O. A meta-analysis of the effects of ipratropium bromide in adults with acute asthma. Am J Med. 1999;107:363-370.

59.  Rodrigo GJ, Rodrigo C. First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department. Am J Respir Crit Care Med. 2000;161:1862-1868.

60.  Lanes SF, Garrett JE, Wentworth CE 3rd, et al. The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials. Chest. 1998;114:365-372.

61.  Plotnick LH, Ducharme FM. Should inhaled anticholinergics be added to beta2 agonists for treating acute childhood and adolescent asthma? A systematic review. BMJ. 1998;317:971-977.

62.  Rowe BH, Bretzlaff JA, Bourdon C, et al. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. Cochrane Database Syst Rev. 2000;(2):CD001490.

63.  Skobeloff EM, Spivey WH, McNamara RM, et al. Intravenous magnesium sulfate for the treatment of acute asthma in the emergency department. JAMA. 1989;262:1210-1213.

64.  Currie GP, Devereux GS, Lee DK, et al. Recent developments in asthma management. BMJ. 2005;330:585-589.

65.  Camargo CA Jr, Smithline HA, Malice MP, et al. A randomized controlled trial of intravenous montelukast in acute asthma. Am J Respir Crit Care Med. 2003;167:528-533.

66.  House SL, Matsuda K, O'Brien G, et al. Efficacy of a new intravenous β2-adrenergic agonist (bedoradrine, MN-221) for patients with an acute exacerbation of asthma. Respir Med. 2015 Oct;109(10):1268-73.

67.  Office for National Statistics. Mortality statistics: deaths registered in 2007. 2008. http://www.statistics.gov.uk (last accessed 14 September 2016).

68.  O'Byrne PM, Barnes PJ, Rodriguez-Roisin R, et al. Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med. 2001;164:1392-1397.

69.  Suissa S, Ernst, P, Benayoun S, et al. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000;343:332-336.

70.  Findley LJ, Sahn SA. The value of chest roentgenograms in acute asthma in adults. Chest. 1981:80:535-536.

71.  Villa-Roel C, Nikel T, Ospina M, et al. Effectiveness of Educational Interventions to Increase Primary Care Follow-up for Adults Seen in the Emergency Department for Acute Asthma: A Systematic Review and Meta-analysis. Acad Emerg Med. 2016 Jan;23(1):5-13.

72.  Cates CJ, Karner C. Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children. Cochrane Database Syst Rev. 2013;(4):CD007313.

73.  Cayetano KS, Chan AL, Albertson TE, et al. Bronchial thermoplasty: a new treatment paradigm for severe persistent asthma. Clin Rev Allergy Immunol. 2012;43:184-193.

74.  Singh SK, Tiwari KK. Bronchial thermoplasty: a non-pharmacological approach. Clin Respir J. 2017 Jan;11(1):13-20.

75.  Kerstjens HA, Engel M, Dahl R, et al. Tiotropium in asthma poorly controlled with standard combination therapy. N Engl J Med. 2012;367:1198-1207.

76.  Tapp S, Lasserson TJ, Rowe B. Education interventions for adults who attend the emergency room for acute asthma. Cochrane Database Syst Rev. 2007;(3):CD003000.

77.  Loymans RJ, Honkoop PJ, Termeer EH, et al. Identifying patients at risk for severe exacerbations of asthma: development and external validation of a multivariable prediction model. Thorax. 2016 Sep;71(9):838-46.

使用此内容应接受我们的免责声明